donald trump glp 1 says U.S. to provide GLP-1 drugs for Medicare patients President Donald Trump unveils major

[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US

doi: 10.1053/j.gastro.2004.04.063

Employers offering weight-loss coverage rose in 2026 from 17% in 2024 Canadian employers are broadening access to glucagon-like peptide-1 (GLP-1) drugs for weight loss, with the share offering that coverage rising to 37 percent in 2026 from 17 percent in 2024

He measured blood glucose levels continuously for 24 hours and found that a single injection of exendin-4 produced sustained glucose lowering throughout the entire day

During our earlier efforts to identify orally available peptides ( 25 ), we recognized the important role that carboxylic acid substituents played in activating the GLP-1R